TAK1 integrates the NLRP1 inflammasome into the innate immune response to double-stranded RNA

Read full text
Authors: Miles R. Corley, Ayumu Hyodo, Hunter C Toyoda, Marisa A. Yonemitsu, Amandine Chantharath, Jennifer Hyde, Patrick S. Mitchell
Cited by: 2
References: 70

Abstract

Innate immune recognition of double-stranded RNA (dsRNA) by germline-encoded receptors initiates antiviral defenses, including type I interferon (IFN) production. The inflammasome-forming sensor NLRP1 binds and is activated by dsRNA in a mitogen-activated protein kinase (MAPK) p38-dependent manner. How dsRNA initiates these events to induce NLRP1 inflammasome activation is unclear. Here we demonstrate that both exogenous and cellular dsRNA triggers NLRP1 inflammasome activation downstream of RIG-I/MDA5-MAVS and/or TLR3-TRIF signaling but is independent of type I IFN. In immortalized and primary human keratinocytes, we find that NLRP1 inflammasome activation by dsRNA, including during viral infection, requires the MAPK kinase kinase TAK1. Mechanistically, TAK1-dependent phosphorylation of the NLRP1 N-terminal disordered region is necessary and sufficient for inflammasome activation. Collectively, we reveal TAK1 as a novel activator of the NLRP1 inflammasome, functioning as a critical signaling hub linking NLRP1 to inflammatory responses in the context of viral infection and autoimmunity.

Fields of Study & Subjects

Inflammasome and immune disorders interferon and immune responses Ocular Diseases and Behçet’s Syndrome

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Publication date
25 January 2026
Language
EN
Document type
Preprint